IRVINE, Calif., Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (EW) today announced the company's EVOQUE tricuspid valve replacement system received CE Mark for the transcatheter ...
Strategic catalysts for 2025 include the U.S. launch of SAPIEN M3 and the introduction of next-gen PASCAL in Q4, with a potential tailwind from an updated National Coverage Determination (NCD) for ...
Edwards Lifesciences said expanded use of its Pascal transcatheter valve repair system drove strong sales in the first quarter as an increasing number of heart centers adopt the technology. Meanwhile, ...
With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results